In breast cancer, in vitro studies showed TIM3 expression in cancer cells that led to apoptosis inhibition, proliferation, invasion,19 and also T cell inhibition in vitro through galectin-9 secretion.76 This evidence concerns the gene HAVCR2 and breast cancer.